1.
Doctors review hemicorporectomy procedures
Friday, November 20
WASHINGTON, Nov. 6 (UPI) -- The U.S. Food and Drug Administration has rejected research data for a long-acting version of the diabetes drug Byetta.
The FDA rejected Eli Lilly's studies comparing small-scale batches of Byetta LAR made by partner Alkermes to large-scale batches made at an Amylin Pharmaceuticals manufacturing plant, Amylin said. Conducting a new study could delay the company's plans to seek approval next year, the Indianapolis Star reported.
The version of Byetta currently on the market is a twice-a-day injectable drug to help diabetics control their blood sugar, the newspaper said.
| Additional News Stories | |
ATLANTA, Nov. 23 (UPI) --
TV chef and author Paula Deen was startled, but not injured when someone accidentally hit her in the face with a ham at a charity event in Atlanta Monday.
|
|
|
|